Anteilseigner
Paul B. Manning (12,50 %) Lawrence J. Steinman (6,36 %) Tiago Reis Marques,
MD, PhD (3,72 %) Adar1 Capital Management LLC (2,65 %) Yassine Bendiabdallah,
PhD (1,44 %) Alfred J. Novak,
MBA (0,34 %) Tower Research Capital LLC (0,13 %) UBS Securities LLC (0,06 %) RBC Dominion Securities, Inc. (Investment Management) (0,02 %) JPMorgan Securities LLC (Investment Management) (0,01 %) Wells Fargo Bank, NA (Private Banking) (0,00 %)
Kontakt
Pasithea Therapeutics Corp.